| Title： | Expert Consensus on RCM Features of Common Non-Melanocytic Skin Tumors |
| Edition： | Original |
| Classification： | Experts consensus |
| Field： | Diagnosis |
| Countries and regions： | China |
| Guidelines users： | All dermatologists and dermatological imaging professionals in various medical and healthcare institutions at all levels who perform RCM examinations for patients. |
| Evidence classification method： | With reference to the Oxford Centre for Evidence-Based Medicine (OCEBM) evidence grading system, the supporting evidence for the recommendation is graded accordingly. 1a: Systematic review based on RCTs (high homogeneity) 1b: Individual RCT study 2a: Systematic evaluation based on cohort studies (high homogeneity) 2b: Individual cohort study and low-quality RCT study 3a: Systematic evaluation based on case-control studies (high homogeneity) 3b: Individual case-control study 4: Case report, low-quality cohort/case-control study 5: Expert opinion |
| Development unit： | China Dermatologist Association |
| Registration time: | 2024-04-30 |
| Registration number： | PREPARE-2024CN605 |
| Purpose of the guideline: | By elucidating the commonly used terms in RCM for non-melanocytic skin tumors and the RCM characteristics of common diseases along with their corresponding histopathological manifestations, we aim to enhance the understanding of the correlation between RCM and histopathology. This will in turn improve diagnostic and therapeutic proficiency, and promote further standardization and application of RCM in the field of non-melanocytic skin tumors. Additionally, filling the gap in our country's guidelines or expert consensus on RCM application in the field of non-melanocytic skin tumors will contribute to the standardization and broader utilization of RCM in clinical practice. |
